Authors:
TOELLNER KM
LUTHER SA
SZE DMY
CHOY RKW
TAYLOR DR
MACLENNAN ICM
ACHAORBEA H
Citation: Km. Toellner et al., T-HELPER-1 (TH1) AND TH2 CHARACTERISTICS START TO DEVELOP DURING T-CELL PRIMING AND ARE ASSOCIATED WITH AN IMMEDIATE ABILITY TO INDUCE IMMUNOGLOBULIN CLASS SWITCHING, The Journal of experimental medicine, 187(8), 1998, pp. 1193-1204
Authors:
LING NR
HARDIE DL
JOHNSON GD
MACLENNAN ICM
Citation: Nr. Ling et al., ORIGIN AND PROPERTIES OF SOLUBLE CD21 (CR-2) IN HUMAN BLOOD, Clinical and experimental immunology, 113(3), 1998, pp. 360-366
Authors:
DRAYSON MT
CHAPMAN CE
DUNN JA
OLUJOHUNGBE AB
MACLENNAN ICM
Citation: Mt. Drayson et al., MRC TRIAL OF INTERFERON-ALPHA-2B MAINTENANCE THERAPY IN FIRST PLATEAU-PHASE OF MULTIPLE-MYELOMA, British Journal of Haematology, 101(1), 1998, pp. 195-202
Authors:
MCCLOSKEY EV
MACLENNAN ICM
DRAYSON MT
CHAPMAN C
DUNN J
KANIS JA
Citation: Ev. Mccloskey et al., A RANDOMIZED TRIAL OF THE EFFECT OF CLODRONATE ON SKELETAL MORBIDITY IN MULTIPLE-MYELOMA, British Journal of Haematology, 100(2), 1998, pp. 317-325
Authors:
MACLENNAN ICM
GULBRANSONJUDGE A
TOELLNER KM
CASAMAYORPALLEJA M
CHAN E
SZE DMY
LUTHER SA
ORBEA HA
Citation: Icm. Maclennan et al., THE CHANGING PREFERENCE OF T-CELL AND B-CELL FOR PARTNERS AS T-DEPENDENT ANTIBODY-RESPONSES DEVELOP, Immunological reviews, 156, 1997, pp. 53-66
Authors:
TURNER M
GULBRANSONJUDGE A
QUINN ME
WALTERS AE
MACLENNAN ICM
TYBULEWICZ VLJ
Citation: M. Turner et al., SYK TYROSINE KINASE IS REQUIRED FOR THE POSITIVE SELECTION OF IMMATURE B-CELLS INTO THE RECIRCULATING B-CELL POOL, The Journal of experimental medicine, 186(12), 1997, pp. 2013-2021
Authors:
LUTHER SA
GULBRANSONJUDGE A
ACHAORBEA H
MACLENNAN ICM
Citation: Sa. Luther et al., VIRAL SUPERANTIGEN DRIVES EXTRAFOLLICULAR AND FOLLICULAR B-CELL DIFFERENTIATION LEADING TO VIRUS-SPECIFIC ANTIBODY-PRODUCTION, The Journal of experimental medicine, 185(3), 1997, pp. 551-562
Authors:
PAO W
WEN L
SMITH AL
GULBRANSONJUDGE A
ZHENG B
KELSOE G
MACLENNAN ICM
OWEN MJ
HAYDAY AC
Citation: W. Pao et al., GAMMA-DELTA T-CELL HELP OF B-CELLS IS INDUCED BY REPEATED PARASITIC INFECTION, IN THE ABSENCE OF OTHER T-CELLS, Current biology, 6(10), 1996, pp. 1317-1325
Authors:
CASAMAYORPALLEJA M
FEUILLARD J
BALL J
DREW M
MACLENNAN ICM
Citation: M. Casamayorpalleja et al., CENTROCYTES RAPIDLY ADOPT A MEMORY B-CELL PHENOTYPE ON COCULTURE WITHAUTOLOGOUS GERMINAL CENTER T-CELL-ENRICHED PREPARATIONS, International immunology, 8(5), 1996, pp. 737-744
Authors:
BRACHTEL EF
WASHIYAMA M
JOHNSON GD
TENNERRACZ K
RACZ P
MACLENNAN ICM
Citation: Ef. Brachtel et al., DIFFERENCES IN THE GERMINAL-CENTERS OF PALATINE TONSILS AND LYMPH-NODES, Scandinavian journal of immunology, 43(3), 1996, pp. 239-247
Authors:
TOELLNER KM
GULBRANSONJUDGE A
TAYLOR DR
SZE DMY
MACLENNAN ICM
Citation: Km. Toellner et al., IMMUNOGLOBULIN SWITCH TRANSCRIPT PRODUCTION IN-VIVO RELATED TO THE SITE AND TIME OF ANTIGEN-SPECIFIC B-CELL ACTIVATION, The Journal of experimental medicine, 183(5), 1996, pp. 2303-2312
Authors:
DRAYSON MT
DUNN JA
OLUJOHUNGBE AB
MACLENNAN ICM
Citation: Mt. Drayson et al., INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL, British Journal of Haematology, 93, 1996, pp. 208-208
Authors:
OLUJOHUNGBE AB
DUNN JA
DRAYSON MT
MACLENNAN ICM
Citation: Ab. Olujohungbe et al., PREDNISOLONE ADDED TO THE ABCM AS TREATMENT FOR MULTIPLE-MYELOMA INCREASES SEROLOGICAL RESPONSES BUT NOT OVERALL SURVIVAL OR THE NUMBER OF STABLE CLINICAL-RESPONSES, British Journal of Haematology, 93, 1996, pp. 296-296
Authors:
DRAYSON MT
DUNN JA
OLUJOHUNGBE AB
MACLENNAN ICM
Citation: Mt. Drayson et al., INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL, Blood, 88(10), 1996, pp. 2332-2332
Authors:
JOHNSON GD
HARDIE DL
KHAN M
NEWTON JP
SIMMONS D
MACLENNAN ICM
Citation: Gd. Johnson et al., REACTIVITY OF THE B-PANEL MABS WITH NONLYMPHOID CONSTITUENTS OF NORMAL-TISSUES, Tissue antigens, 48(4-II), 1996, pp. 208-208
Authors:
MCCLOSKEY EV
MACLENNAN ICM
DRAYSON M
CHAPMAN C
DUNN J
KANIS JA
Citation: Ev. Mccloskey et al., EFFECT OF CLODRONATE ON PROGRESSION OF SKELETAL DISEASE IN MULTIPLE MYELOMATOSIS, European journal of cancer, 31A, 1995, pp. 775-775
Authors:
FEUILLARD J
TAYLOR D
CASAMAYORPALLEJA M
JOHNSON GD
MACLENNAN ICM
Citation: J. Feuillard et al., ISOLATION AND CHARACTERISTICS OF TONSIL CENTROBLASTS WITH REFERENCE TO IG CLASS SWITCHING, International immunology, 7(1), 1995, pp. 121-130
Authors:
JONES NA
ROWLANDS DC
JOHNSON WEB
MACLENNAN ICM
BROWN G
Citation: Na. Jones et al., PERSISTENT GROWTH OF BALB C MOUSE PLASMACYTOMA AND HUMAN MYELOMA CELL-LINES IN THE PRESENCE OF PHORBOL-MYRISTATE ACETATE IS ASSOCIATED WITHCONTINUED EXPRESSION OF LAP18 (STATHMIN)/, Hematological oncology, 13(1), 1995, pp. 29-43